PharmaShots | Incisive News in 3 Shots

Subscribe Now

alnylam pharmaceuticals

Alnylam Pharmaceuticals Reports the US FDA’s sNDA Acceptance of Amvuttra (Vutrisiran) to Treat ATTR Amyloidosis with Cardiomyopathy

Alnylam Pharmaceuticals Reports the US FDA’s sNDA Acceptance of Amvuttra (Vutrisiran) to Treat ATTR Amyloidosis with Cardiomyopath...

November 26, 2024

Alnylam Reports the Submission of Regulatory Application of Amvuttra (Vutrisiran) to the EMA Treating ATTR Amyloidosis with Cardiomyopathy

Alnylam Reports the Submission of Regulatory Application of Amvuttra (Vutrisiran) to the EMA Treating ATTR Amyloidosis with Cardio...

October 17, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us